Wall Street Experts
ver. ZuMIgo(08/25)
Galectin Therapeutics Inc.
Rachunek Zysków i Strat
Przychody TTM (mln): 0
EBIT TTM (mln): -40
index |
0 |
1 |
2 |
3 |
4 |
5 |
6 |
7 |
8 |
9 |
10 |
11 |
12 |
13 |
14 |
15 |
16 |
17 |
18 |
19 |
20 |
21 |
22 |
23 |
24 |
Rok finansowy |
2000 |
2001 |
2002 |
2003 |
2004 |
2005 |
2006 |
2007 |
2008 |
2009 |
2010 |
2011 |
2012 |
2013 |
2014 |
2015 |
2016 |
2017 |
2018 |
2019 |
2020 |
2021 |
2022 |
2023 |
2024 |
Przychód (mln) |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
Przychód Δ r/r |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
Marża brutto |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
-inf% |
-inf% |
-inf% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
-inf% |
-inf% |
-inf% |
-inf% |
-inf% |
0.0% |
EBIT (mln) |
-0 |
-2 |
-3 |
-5 |
-7 |
-7 |
-7 |
-6 |
-5 |
-6 |
-5 |
-10 |
-10 |
-12 |
-15 |
-20 |
-21 |
-16 |
-14 |
-13 |
-23 |
-30 |
-38 |
-38 |
0 |
EBIT Δ r/r |
0.0% |
1183.6% |
50.6% |
50.2% |
47.9% |
-8.9% |
5.9% |
-8.4% |
-17.5% |
14.4% |
-19.9% |
113.2% |
-4.9% |
22.3% |
27.5% |
30.1% |
7.0% |
-24.4% |
-16.3% |
-1.2% |
74.5% |
28.7% |
27.1% |
-0.7% |
-100.0% |
EBIT (%) |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
Koszty finansowe (mln) |
0 |
0 |
0 |
0 |
0 |
0 |
-2 |
-0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
-3 |
-6 |
EBITDA (mln) |
-0 |
-2 |
-3 |
-5 |
-7 |
-7 |
-12 |
-4 |
-7 |
-5 |
-4 |
-10 |
-10 |
-12 |
-15 |
-20 |
-21 |
-16 |
-14 |
-13 |
-23 |
-30 |
-38 |
-38 |
0 |
EBITDA(%) |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
Podatek (mln) |
0 |
2 |
0 |
0 |
0 |
0 |
-4 |
3 |
-2 |
1 |
1 |
1 |
0 |
0 |
-0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
Zysk Netto (mln) |
-0 |
-4 |
-4 |
-5 |
-7 |
-7 |
-3 |
-9 |
-3 |
-7 |
-6 |
-11 |
-10 |
-12 |
-16 |
-20 |
-21 |
-16 |
-14 |
-13 |
-24 |
-31 |
-39 |
-41 |
-47 |
Zysk netto Δ r/r |
0.0% |
1989.6% |
-7.4% |
32.5% |
47.3% |
-8.9% |
-51.2% |
195.4% |
-66.6% |
136.8% |
-24.6% |
93.9% |
-11.4% |
24.9% |
30.6% |
26.8% |
7.0% |
-24.3% |
-14.4% |
-3.7% |
75.7% |
31.7% |
26.6% |
4.8% |
14.6% |
Zysk netto (%) |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
nan |
EPS |
-0.0922 |
-1.75 |
-1.35 |
-1.37 |
-1.67 |
-1.44 |
-0.67 |
-1.45 |
-0.4 |
-0.93 |
-0.6 |
-0.91 |
-0.64 |
-0.72 |
-0.72 |
-0.83 |
-0.73 |
-0.46 |
-0.35 |
-0.26 |
-0.41 |
-0.53 |
-0.66 |
-0.68 |
-0.76 |
EPS (rozwodnione) |
-0.0922 |
-1.75 |
-1.35 |
-1.37 |
-1.67 |
-1.44 |
-0.67 |
-1.45 |
-0.4 |
-0.93 |
-0.6 |
-0.91 |
-0.64 |
-0.72 |
-0.72 |
-0.83 |
-0.73 |
-0.46 |
-0.35 |
-0.26 |
-0.41 |
-0.53 |
-0.66 |
-0.68 |
-0.76 |
Ilośc akcji (mln) |
2 |
2 |
3 |
4 |
4 |
5 |
5 |
6 |
8 |
8 |
9 |
12 |
15 |
17 |
22 |
24 |
29 |
36 |
39 |
52 |
57 |
59 |
59 |
60 |
62 |
Ważona ilośc akcji (mln) |
2 |
2 |
3 |
4 |
4 |
5 |
5 |
6 |
8 |
8 |
9 |
12 |
15 |
17 |
22 |
24 |
29 |
36 |
39 |
52 |
57 |
59 |
59 |
60 |
62 |
Waluta |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |